JANX - Janux Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JANX is currently covered by 7 analysts with an average price target of $75.12. This is a potential upside of $45.11 (150.32%) from yesterday's end of day stock price of $30.01.

Janux Therapeutics's activity chart (see below) currently has 5 price targets and 36 ratings on display. The stock rating distribution of JANX is 90.63% BUY and 9.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.23% with an average time for these price targets to be met of 270.71 days.

Highest price target for JANX is $200, Lowest price target is $62, average price target is $96.29.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 03-Mar-2025. First documented stock forecast 06-Jul-2021.

Currently out of the existing stock ratings of JANX, 29 are a BUY (90.63%), 3 are a HOLD (9.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$70

$40.31 (135.77%)

$70

1 months 19 days ago
(03-Mar-2025)

10/12 (83.33%)

$38.17 (119.92%)

252

Buy

$200

$170.31 (573.63%)

$200

4 months 11 days ago
(11-Dec-2024)

1/7 (14.29%)

$136.55 (215.21%)

966

Hold

$62

$32.31 (108.82%)

$42

4 months 18 days ago
(04-Dec-2024)

3/3 (100%)

$-4.84 (-7.24%)

7

Buy

$115

$85.31 (287.34%)

$70

4 months 19 days ago
(03-Dec-2024)

0/2 (0%)

$55.14 (92.11%)

Buy

$105

$75.31 (253.65%)

$70

4 months 19 days ago
(03-Dec-2024)

0/2 (0%)

$45.14 (75.41%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JANX (Janux Therapeutics) average time for price targets to be met?

On average it took 270.71 days on average for the stock forecasts to be realized with a an average price target met ratio 53.23

Which analyst has the current highest performing score on JANX (Janux Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on JANX (Janux Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on JANX (Janux Therapeutics)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 6 price targets and 7 ratings on JANX

Which analyst is the currently most bullish on JANX (Janux Therapeutics)?

Josh Schimmer with highest potential upside - $170.31

Which analyst is the currently most reserved on JANX (Janux Therapeutics)?

Geoff Meacham with lowest potential downside - $18.31

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?